Hepatitis B vaccine after newborn surgery
Part of Blood & lymphatic, Digestive system, Immune system & allergy, Infections clinical trials.
This trial tests whether giving the hepatitis B vaccine to full-term newborns who had multiple stomach or intestine surgeries is safe and works well. It aims to protect these babies from hepatitis B infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born full-term (not premature).
- Your baby had multiple surgeries on their stomach or intestines.
- Your baby does not have hepatitis B (tested negative).
- Your baby has no problems with their immune system.
- Your baby does not have serious issues with their heart, brain, liver, kidneys, or other major organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's immune system responds in people with chronic hepatitis B who also need surgery on certain organs. The goal is to learn more about the immune reaction in tonsils, lymph nodes, or other tissues to help find better treatments for hepatitis B.
This study looks at the best time to give the hepatitis B vaccine after a stem cell transplant. It may help your body build protection against hepatitis B more effectively after your transplant.
This study tests whether two different hepatitis B vaccines can be used interchangeably for the first dose given at birth. It aims to ensure both vaccines protect newborns equally well.
This study tests a new hepatitis B vaccine to see if it is safe and helps the body fight the virus. It is for healthy people who have not had a hepatitis B vaccine in the last 10 years.
This study tests antiviral medicine in babies under 1 year old who have hepatitis B. The goal is to see if early treatment can help clear the virus and protect the liver.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
Hear when a new Vaccination Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.